HGH and HGH Fragment 176-191 Interaction

Monitor
Researched 90% confidence

HGH and HGH Fragment 176-191 have an interaction requiring monitoring for interaction with 90% confidence. Redundant lipolytic mechanism. Full HGH already contains the 176-191 sequence, so combining provides diminishing returns for fat loss while adding HGH-related side effects. Both compounds affect the gi tract, so monitoring these systems is recommended.

Compound Profiles

HGH

Human Growth Hormone | Somatropin

Binds to GH receptors on target tissues, triggering JAK2-STAT5 signaling pathway. Direct effects include lipolysis, protein synthesis, and metabolic regulation.

Half-life: 3-4 hours (SC), 20-30 minutes (IV) Typical dose: 1-4 IU daily (0.33-1.33mg); start low and titrate up growth hormone, weight loss, healing
gh directigf1 carcinogenic riskestrogenicinsulin disruptingteratogenic
View full profile

HGH Fragment 176-191

Growth Hormone Fragment | Fat Loss Peptide

Mimics the lipolytic region of human growth hormone by stimulating fat breakdown through beta-3 adrenergic receptor pathways. Unlike full HGH, it does not bind the growth hormone receptor, so it does not increase IGF-1 levels or interfere with glucose metabolism.

Half-life: 15-20 minutes Typical dose: 250-500mcg weight loss, metabolic
carcinogenic riskinsulin disruptingteratogenic
View full profile

Combined Organ Load

GI Tract
low
Blood Vessels
low
Pituitary
low
Pancreas
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (HGH, HGH Fragment 176-191). Monitor accordingly.
2x 2 compounds affect insulin sensitivity (HGH, HGH Fragment 176-191). Monitor fasting glucose and HbA1c.
2x 2 compounds share the teratogenic safety flag (HGH, HGH Fragment 176-191). Monitor accordingly.

Frequently Asked Questions

Can I take HGH with HGH Fragment 176-191?

Yes, but with caution. Redundant lipolytic mechanism. Full HGH already contains the 176-191 sequence, so combining provides diminishing returns for fat loss while adding HGH-related side effects. Regular monitoring is advised.

Is HGH and HGH Fragment 176-191 safe together?

Based on documented research, this combination is considered monitor. However, shared safety flags include: carcinogenic risk, insulin disrupting, teratogenic. Monitor accordingly.

What are the interactions between HGH and HGH Fragment 176-191?

Redundant lipolytic mechanism. Full HGH already contains the 176-191 sequence, so combining provides diminishing returns for fat loss while adding HGH-related side effects. This assessment has 90% confidence and is based on documented research data.

How should I time HGH and HGH Fragment 176-191?

HGH has a half-life of 3-4 hours (SC), 20-30 minutes (IV) and HGH Fragment 176-191 has a half-life of 15-20 minutes. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: HGH vs HGH Fragment 176-191

This interaction analysis is compiled from research literature and pharmacological mechanism data. Always consult a healthcare professional before combining compounds.